Glycosylated hemoglobin (HbA1c) 
Introduction
Measurement of glycosylated hemoglobin (HbA1c) is a fundamental component of the management of patients with diabetes mellitus, i. e, to monitor long-term glycemic status, to judge the adequacy of diabetes management and to adjust therapies. 1 Epidemiologic studies and clinical trial established the association of HbA1c with the risk for longterm complications of hyperglycemia. 2, 3, 4 The A1c Derived Average Glucose (ADAG) Study defined the mathematical relationship between HbA1c and average glucose (AG), similar to the mathematical relationship of HbA1c and Mean Plasma glucose (MPG) in the Diabetes Control and Complication Trial (DCCT). 5, 6 The DCCT trial included only 1439 type 1 diabetic subjects whereas ADAG study included 507 subjects including 268 type 1, 159 type 2 diabetic subjects and 80 nondiabetic subjects. The correlation coefficient of HbA1c with AG is higher than the correlation coefficient of HbA1c with MPG (0.92 vs 0.82). The ADAG study included stable hyperglycemic subjects. But this study included lower number of participants from
Relationship of Glycosylated Hemoglobin with Fasting and Postprandial Plasma
Glucose in Nondiabetic, Pre-diabetic and Newly Diagnosed Diabetic Subjects complications of diabetes. The correlation of FPG with HbA1c is slightly higher than the correlation of PPG with HbA1c in the newly diagnosed diabetic subjects in this study. Moreover, the correlation coefficient of FPG with HbA1c is closer to DCCT 6 (0.80 vs 0.82). So evaluation of FPG may be a better tool than PPG for the diagnosis, management and prognosis in the newly diagnosed never treated diabetic subjects.
Conclusion
This study revealed that fasting plasma glucose had a modest higher relation with HbA1c than 2 hours postprandial plasma glucose in the newly diagnosed diabetic subjects. It can be concluded that evaluation of FPG may be a better tool than PPG for the diagnosis, management and prognosis in the newly diagnosed never treated diabetic subjects.
Results
The mean±SD of age of the total study subjects were 43.66±12.33 years (range: 11-85 years). Of the total, 279 (39.86%) were male with mean age of 47.08±11.60 years and 421 (60.14%) were female with mean age of 41.39±12.30 years. Mean±SD of age, number of subjects, FPG, PPG and HbA1c of the four groups are presented in table I. The correlation coefficient of FPG and PPG with HbA1c in the total study subjects were 0.8623 (P<0.001), 0.8574 (P<0.001) respectively. In the nondiabetic group, the correlation coefficient of FPG and PPG with HbA1c were 0.2495 (P<0.001) and -0.0661 (P>0.05) respectively. In the prediabetic group the correlation coefficient of FPG and PPG with HbA1c were 0.2665 (P<0.001) and 0.2447 (P<0.01) respectively. The Pearson's correlation coefficient of FPG and PPG with HbA1c in the diabetic subjects were 0.8012 (P<0.001) and 0.7812 (P<0.001). Table I . Characteristics of the diabetic, prediabetic and nondiabetic groups.
Discussion
Our results indicate that the correlation coefficient between FPG and HbA1c is statistically highly significant (P<0.001) and slightly higher than the statistically significant (P<0.001) correlation coefficient between PPG and HbA1c in the newly diagnosed diabetic subjects (0.8010 vs 0.7812). In the pre-diabetic group, the correlation coefficient of FPG and PPG with HbA1c are statistically significant (P<0.001, P<0.01), but the correlation coefficient between FPG and HbA1c is stronger than the correlation coefficient between PPG and HbA1c (0.2665 vs 0.2447). The correlation coefficient of plasma glucose with HbA1c in the pre-diabetic group are weaker than the correlation coefficient of plasma glucose with HbA1c in newly diagnosed diabetic subjects. It is also found that only FPG showed significant correlation with HbA1c in nondiabetic subjects.
